Enteris supports clients through all stages of development for solid oral dosage forms, from formulation and analytical method development to clinical and commercial cGMP manufacturing.
Our 32,000 square foot state-of-the-art cGMP facility is equipped to handle a myriad of APIs, including dedicated processing and containment areas for highly potent API (HPAPI). We provide total integrated CMC support, including preformulation, formulation, analytical R&D, quality control & quality assurance, clinical & commercial manufacturing, and regulatory assistance.
Our clients have direct access to our CMC experts, allowing for rapid problem solving, specialized project management, and efficient project completion.
